{
  "url": "https://openlegislation.uk/eu-directive-2010-87/annex",
  "json_url": "https://openlegislation.uk/eu-directive-2010-87/annex.json",
  "legislation": "eudr/2010/87",
  "legislation_title": "Commission Directive 2010/87/EU of 3 December 2010 amending Council Directive 91/414/EEC to include fenbuconazole as active substance and amending Decision 2008/934/EC (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-directive-2010-87",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "The following entry shall be added at the end of the table in Annex I to Directive 91/414/EC:\nFurther details on identity and specification of active substance are provided in the review report.\nNo\nCommon Name, Identification Numbers\nIUPAC Name\nPurity\nEntry into force\nExpiration of inclusion\nSpecific provisions\n‘320\nFenbuconazole\nCAS No: 114369-43-6\nCIPAC No: 694\n(R,S) 4-(4-chlorophenyl)-2-phenyl-2-(1H-1,2,4-triazol-1-ylmethyl)butyronitrile\n≥ 965 g/kg\n1 May 2011\n30 April 2021\nPART A\nOnly uses as fungicide may be authorised.\nPART B\nFor the implementation of the uniform principles of Annex VI, the conclusions of the review report on fenbuconazole, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 October 2010 shall be taken into account.\nIn this overall assessment Member States shall pay particular attention to:\nthe operator safety and ensure that conditions of use prescribe the application of adequate personal protective equipment where appropriate,\nthe dietary exposure of consumers to the residues of triazole derivative metabolites (TDMs),\nthe risk to aquatic organisms and mammals.\nConditions of use shall include risk mitigation measures, where appropriate.\nThe Member States concerned shall request the submission of confirmatory data on residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin.\nThey shall ensure that the applicant provides such studies to the Commission by 30 April 2013.\nThe Member States concerned shall ensure that the applicant submits to the Commission further information addressing the potential endocrine disrupting properties of fenbuconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, of Community agreed test guidelines.’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Further details on identity and specification of active substance are provided in the review report."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/2010/87/annex",
    "retrieved_at": "2026-11-01T14:42:04.987023+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}